Expression of cancer testis (CT) antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM), correlation with prognostic factors and potential role in a melanoma vaccine

被引：0
|
作者：
Velazquez, EF
Jungbluth, AA
Osman, I
Yancovitz, M
Adams, S
O'Neill, D
Zavilevich, K
Albukh, T
Pavlick, A
Polsky, D
Shapiro, R
Berman, R
Spira, J
Busam, K
Bhardwaj, N
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Ludwig Inst Canc Res, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
400
引用
收藏
页码：89A / 89A
页数：1
相关论文
共 50 条
  • [31] Expression and prognostic significance of cancer testis antigens in primary mucosal melanoma (MM) of the head and neck
    Prasad, ML
    Jungbluth, AA
    Iversen, K
    Huvos, AG
    Busam, KJ
    LABORATORY INVESTIGATION, 2002, 82 (01) : 307A - 307A
  • [32] Expression and prognostic significance of cancer testis antigens in primary mucosal melanoma (MM) of the head and neck
    Prasad, ML
    Jungbluth, AA
    Iversen, K
    Huvos, AG
    Busam, KJ
    MODERN PATHOLOGY, 2002, 15 (01) : 307A - 307A
  • [33] Transient expression of the cancer/testis cancer antigen NY-ESO-1 in Nicotiana benthamiana using a PVX-based viral vector
    Cristiano Lacorte
    Jéssica Carrijo
    André Murad
    Elíbio Rech
    BMC Proceedings, 8 (Suppl 4)
  • [34] Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1
    Iura, Kunio
    Maekawa, Akira
    Kohashi, Kenichi
    Ishii, Takeaki
    Bekki, Hirofumi
    Otsuka, Hiroshi
    Yamada, Yuichi
    Yamamoto, Hidetaka
    Harimaya, Katsumi
    Iwamoto, Yukihide
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2017, 61 : 130 - 139
  • [35] NY-ESO-1 protein-based immunotherapy for malignant melanoma: Tumor antigen-specific T cell responses and suppressive phenomenon
    Tsuji, K.
    Hamada, T.
    Asagoe, K.
    Wada, H.
    Kawabata, R.
    Aji, T.
    Uenaka, A.
    Shiku, H.
    Nakayama, E.
    Iwatsuki, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 104 - 104
  • [36] Evidence for immunological pressure and escape from longitudinal analysis of the expression of and immune responses against NY-ESO-1 in a patient with metastatic melanoma
    von Boehmer, Lotta
    Landshammer, Alexandro
    Nuber, Natko
    Bode, Peter
    Moch, Holger
    Jaeger, Elke
    Knuth, Alexander
    van den Broek, Maries
    CANCER RESEARCH, 2011, 71
  • [37] EXPRESSION OF THE TUMOR-ASSOCIATED ANTIGENS TYROSINASE, MAGE-A3, NY-ESO-1 AND TPTE IN PEDIATRIC MELANOMA AND THEIR CORRELATION WITH PROGNOSIS
    Forchhammer, Stephan
    Pop, Oltin
    Hahn, Matthias
    Aebischer, Valentin
    Seitz, Christian
    Schroeder, Christopher
    Liebmann, Alexandra
    Abele, Michael
    Wild, Hannah
    Bien, Ewa
    Schneider, Dominik
    Buettel, Isabel
    Flemmig, Carina
    Peters, Magdalena
    Laible, Mark
    Brueck, Patrick
    Tuereci, Oezlem
    Sahin, Ugur
    Flatz, Lukas
    Brecht, Ines
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S125 - S126
  • [38] Immunization of HLA-A*0201 and/or HLA-DPβ1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen
    Khong, HT
    Yang, JC
    Topalian, SL
    Sherry, RM
    Mavroukakis, SA
    White, DE
    Rosenberg, SA
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : 472 - 477
  • [39] Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7
    Jungbluth, AA
    Antonescu, CR
    Busam, KJ
    Iversen, K
    Kolb, D
    Coplan, D
    Chen, YT
    Stockert, E
    Ladanyi, M
    Old, LJ
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) : 252 - 256
  • [40] Fine analysis of spontaneous and vaccine-induced immune responses to the broadly-expressed cancer-testis antigen, NY-ESO-1
    Knights, A.
    de la Rosa, O.
    Nuber, N.
    Renner, C.
    Knuth, A.
    Zippelius, A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (03) : 424 - 424
12345